RU2526911C2 - Эмульсия "масло-в-воде" мометазона и пропиленгликоля - Google Patents

Эмульсия "масло-в-воде" мометазона и пропиленгликоля Download PDF

Info

Publication number
RU2526911C2
RU2526911C2 RU2011150246/15A RU2011150246A RU2526911C2 RU 2526911 C2 RU2526911 C2 RU 2526911C2 RU 2011150246/15 A RU2011150246/15 A RU 2011150246/15A RU 2011150246 A RU2011150246 A RU 2011150246A RU 2526911 C2 RU2526911 C2 RU 2526911C2
Authority
RU
Russia
Prior art keywords
oil
water emulsion
mometasone
water
propylene glycol
Prior art date
Application number
RU2011150246/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2011150246A (ru
Inventor
Хенри Ханссон
Анна Карин МОРЕН
Original Assignee
Галеника Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Галеника Аб filed Critical Галеника Аб
Publication of RU2011150246A publication Critical patent/RU2011150246A/ru
Application granted granted Critical
Publication of RU2526911C2 publication Critical patent/RU2526911C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
RU2011150246/15A 2009-05-12 2010-05-12 Эмульсия "масло-в-воде" мометазона и пропиленгликоля RU2526911C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200900601 2009-05-12
DKPA200900601 2009-05-12
PCT/EP2010/002921 WO2010130428A1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol

Publications (2)

Publication Number Publication Date
RU2011150246A RU2011150246A (ru) 2013-06-20
RU2526911C2 true RU2526911C2 (ru) 2014-08-27

Family

ID=42352732

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011150246/15A RU2526911C2 (ru) 2009-05-12 2010-05-12 Эмульсия "масло-в-воде" мометазона и пропиленгликоля

Country Status (20)

Country Link
US (2) US8728497B2 (cg-RX-API-DMAC10.html)
EP (2) EP2429510B1 (cg-RX-API-DMAC10.html)
JP (2) JP5833541B2 (cg-RX-API-DMAC10.html)
CN (1) CN102458382B (cg-RX-API-DMAC10.html)
AU (1) AU2010246613B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI1010907B8 (cg-RX-API-DMAC10.html)
CA (1) CA2761739C (cg-RX-API-DMAC10.html)
CY (1) CY1116667T1 (cg-RX-API-DMAC10.html)
DK (1) DK2429510T3 (cg-RX-API-DMAC10.html)
ES (2) ES2547556T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20150959T1 (cg-RX-API-DMAC10.html)
HU (1) HUE027718T2 (cg-RX-API-DMAC10.html)
MX (1) MX345888B (cg-RX-API-DMAC10.html)
NZ (1) NZ596429A (cg-RX-API-DMAC10.html)
PL (2) PL2429510T3 (cg-RX-API-DMAC10.html)
PT (1) PT2429510E (cg-RX-API-DMAC10.html)
RU (1) RU2526911C2 (cg-RX-API-DMAC10.html)
SI (1) SI2429510T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201500297B (cg-RX-API-DMAC10.html)
WO (1) WO2010130428A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2429510T3 (en) 2009-05-12 2015-09-28 Galenica Ab The oil-in-water emulsion mometasone and propylene glycol
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
WO2019082873A1 (ja) * 2017-10-23 2019-05-02 マルホ株式会社 被膜形成外用剤
US20190282465A1 (en) * 2018-03-19 2019-09-19 Essential Lipid Technologies, LLC Topical Phospholipid Formulations and Methods for Preparing the Same
JP2026501094A (ja) * 2022-12-20 2026-01-14 ガレニカ デルマ エービー 局所的皮膚処置のための新規な組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5874074A (en) * 1992-12-16 1999-02-23 Creative Products Resource Associates Inc. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282216A (en) * 1977-04-20 1981-08-04 Johnson & Johnson Topical anti-inflammatory drug therapy
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
TR200201343A2 (tr) * 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
SI1542904T1 (sl) 2002-08-27 2008-06-30 Schering Corp Postopek za izdelavo inhalacijskih formulacij z merjenim odmerkom
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
WO2004105686A2 (en) * 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
EP1631290A2 (en) 2003-05-23 2006-03-08 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
DE102006034883A1 (de) 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
WO2008126076A2 (en) * 2007-04-11 2008-10-23 Perrigo Israel Pharmaceuticals Ltd. Low-dose mometasone formulations
PL2429490T3 (pl) 2009-05-12 2017-06-30 Galenica Ab Emulsja mometazonu typu olej-w-wodzie
DK2429510T3 (en) 2009-05-12 2015-09-28 Galenica Ab The oil-in-water emulsion mometasone and propylene glycol

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US5874074A (en) * 1992-12-16 1999-02-23 Creative Products Resource Associates Inc. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition

Also Published As

Publication number Publication date
HRP20150959T1 (hr) 2015-11-06
PT2429510E (pt) 2015-10-12
BRPI1010907B8 (pt) 2021-05-25
SMT201500297B (it) 2016-01-08
WO2010130428A1 (en) 2010-11-18
US8728497B2 (en) 2014-05-20
AU2010246613A1 (en) 2011-12-08
RU2011150246A (ru) 2013-06-20
JP2012526738A (ja) 2012-11-01
EP2962688B1 (en) 2020-06-24
AU2010246613B2 (en) 2014-07-17
BRPI1010907B1 (pt) 2020-10-20
PL2429510T3 (pl) 2015-12-31
US11395827B2 (en) 2022-07-26
HUE027718T2 (en) 2016-10-28
EP2962688A1 (en) 2016-01-06
MX345888B (es) 2017-02-22
ES2547556T3 (es) 2015-10-07
MX2011011959A (es) 2012-05-08
PL2962688T3 (pl) 2020-11-02
DK2429510T3 (en) 2015-09-28
SI2429510T1 (sl) 2015-10-30
US20120171252A1 (en) 2012-07-05
EP2429510B1 (en) 2015-06-24
CY1116667T1 (el) 2017-03-15
JP5833541B2 (ja) 2015-12-16
EP2429510A1 (en) 2012-03-21
CN102458382B (zh) 2015-03-18
CA2761739C (en) 2017-03-07
JP2015227354A (ja) 2015-12-17
CN102458382A (zh) 2012-05-16
ES2813400T3 (es) 2021-03-23
BRPI1010907A2 (pt) 2016-03-15
CA2761739A1 (en) 2010-11-18
US20140242171A1 (en) 2014-08-28
NZ596429A (en) 2013-08-30

Similar Documents

Publication Publication Date Title
DE60014162T2 (de) Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung
JP5694944B2 (ja) エマルション系局所治療用製剤の保存方式
AU2017200040A1 (en) Semisolid aqueous pharmaceutical composition containing tapentadol
US11395827B2 (en) Oil-in-water emulsion of mometasone and propylene glycol
CN103476396B (zh) 包含环状缩酚肽的混悬类型的局部制剂
JP2022501314A (ja) 局所用組成物
US20220331238A1 (en) Oil-in-water emulsion of mometasone
JPWO2020022368A1 (ja) 液状外用剤
EP2952207B1 (en) Oil based pharmaceutical compositions for oral administration
JP4060347B2 (ja) ２２−オキサ−１α，２５−ジヒドロキシビタミンＤ３を含有する水中油型乳剤性ローション剤
JP6503627B2 (ja) 医薬液体組成物
JP6084579B2 (ja) タクロリムスを含有する水中油型クリーム状組成物
US20240299378A1 (en) Emulsion for use in the treatment of rosacea
RU2649809C2 (ru) Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CA3163637A1 (en) Topical pharmaceutical formulation